These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 8622873
21. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD. Cancer Res; 1995 Mar 15; 55(6):1227-31. PubMed ID: 7882313 [Abstract] [Full Text] [Related]
22. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Gunduz M, Ouchida M, Fukushima K, Ito S, Jitsumori Y, Nakashima T, Nagai N, Nishizaki K, Shimizu K. Oncogene; 2002 Jun 27; 21(28):4462-70. PubMed ID: 12080476 [Abstract] [Full Text] [Related]
23. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias. Yoo NJ, Park SW, Lee SH. Pathology; 2012 Jan 27; 44(1):29-32. PubMed ID: 22081132 [Abstract] [Full Text] [Related]
24. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Kim SK, Fan Y, Papadimitrakopoulou V, Clayman G, Hittelman WN, Hong WK, Lotan R, Mao L. Cancer Res; 1996 Jun 01; 56(11):2519-21. PubMed ID: 8653689 [Abstract] [Full Text] [Related]
25. Inactivation of Smad4 in gastric carcinomas. Powell SM, Harper JC, Hamilton SR, Robinson CR, Cummings OW. Cancer Res; 1997 Oct 01; 57(19):4221-4. PubMed ID: 9331080 [Abstract] [Full Text] [Related]
26. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition. Herbst A, Bommer GT, Kriegl L, Jung A, Behrens A, Csanadi E, Gerhard M, Bolz C, Riesenberg R, Zimmermann W, Dietmaier W, Wolf I, Brabletz T, Göke B, Kolligs FT. Gastroenterology; 2009 Aug 01; 137(2):639-48, 648.e1-9. PubMed ID: 19394332 [Abstract] [Full Text] [Related]
27. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO, Park JG. Oncogene; 2004 Sep 02; 23(40):6736-42. PubMed ID: 15273736 [Abstract] [Full Text] [Related]
28. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway. Woodford-Richens KL, Rowan AJ, Gorman P, Halford S, Bicknell DC, Wasan HS, Roylance RR, Bodmer WF, Tomlinson IP. Proc Natl Acad Sci U S A; 2001 Aug 14; 98(17):9719-23. PubMed ID: 11481457 [Abstract] [Full Text] [Related]
29. Activation but not inactivation of the MTS1 gene is associated with primary colorectal carcinomas. Ohhara M, Esumi M, Kurosu Y. Biochem Biophys Res Commun; 1996 Sep 24; 226(3):791-5. PubMed ID: 8831691 [Abstract] [Full Text] [Related]
30. p300 gene alterations in intestinal and diffuse types of gastric carcinoma. Koshiishi N, Chong JM, Fukasawa T, Ikeno R, Hayashi Y, Funata N, Nagai H, Miyaki M, Matsumoto Y, Fukayama M. Gastric Cancer; 2004 Sep 24; 7(2):85-90. PubMed ID: 15224194 [Abstract] [Full Text] [Related]
31. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH. Mantripragada KK, Buckley PG, Benetkiewicz M, De Bustos C, Hirvelä C, Jarbo C, Bruder CE, Wensman H, Mathiesen T, Nyberg G, Papi L, Collins VP, Ichimura K, Evans G, Dumanski JP. Int J Oncol; 2003 Mar 24; 22(3):615-22. PubMed ID: 12579316 [Abstract] [Full Text] [Related]
32. Intronic deletion affecting a negative regulatory region of TP73 is related to breast and colorectal carcinomas. Peña C, Garcia JM, Dominguez G, Silva J, Garcia V, Carcereny E, Vargas J, Provencio M, España P, Bonilla F. Genes Chromosomes Cancer; 2004 Mar 24; 39(3):257-62. PubMed ID: 14732927 [Abstract] [Full Text] [Related]
33. p300/CBP and cancer. Iyer NG, Ozdag H, Caldas C. Oncogene; 2004 May 24; 23(24):4225-31. PubMed ID: 15156177 [Abstract] [Full Text] [Related]
34. Genetic alterations of the KLF6 gene in gastric cancer. Cho YG, Kim CJ, Park CH, Yang YM, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS. Oncogene; 2005 Jun 30; 24(28):4588-90. PubMed ID: 15824733 [Abstract] [Full Text] [Related]
35. Neurofibromatosis 2 gene in human colorectal cancer. Rustgi AK, Xu L, Pinney D, Sterner C, Beauchamp R, Schmidt S, Gusella JF, Ramesh V. Cancer Genet Cytogenet; 1995 Oct 01; 84(1):24-6. PubMed ID: 7497438 [Abstract] [Full Text] [Related]
36. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A. Int J Oncol; 2002 May 01; 20(5):905-11. PubMed ID: 11956582 [Abstract] [Full Text] [Related]
37. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation. Leung SY, Yuen ST, Chan TL, Chan AS, Ho JW, Kwan K, Fan YW, Hung KN, Chung LP, Wyllie AH. Oncogene; 2000 Aug 17; 19(35):4079-83. PubMed ID: 10962567 [Abstract] [Full Text] [Related]
38. Genetic alterations of the KLF6 gene in colorectal cancers. Cho YG, Choi BJ, Kim CJ, Song JW, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS. APMIS; 2006 Jun 17; 114(6):458-64. PubMed ID: 16856969 [Abstract] [Full Text] [Related]
39. Genetic alterations in human gastric cancer. Hirohashi S, Sugimura T. Cancer Cells; 1991 Feb 17; 3(2):49-52. PubMed ID: 2029453 [Abstract] [Full Text] [Related]
40. Evidence for a new tumor-suppressor gene involved in gastrointestinal malignancies. Wasylyshyn ML, Neuman WL, Angriman I, Snyder LA, Montag AG, Westbrook CA, Michelassi F. Surgery; 1991 Aug 17; 110(2):265-8; discussion 268-9. PubMed ID: 1858037 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]